Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179374 · ClinicalTrials.gov registry record · NA
Improving Diabetes Outcomes With Activity, Nutrition and Medication
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 556
- Enrollment target
NCT00179374: Completed NA study, sponsored by Albert Einstein College of Medicine.
NCT00179374 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 556 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179374, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 556 participants
- Enrollment target
Study Summary
This study has the following specific aims: 1. A tailored telephone intervention will significantly improve medication adherence compared to a standard care intervention. 2. A tailored telephone intervention will significantly improve metabolic control measured by HbA1c compared to a standard care intervention 2a) We will explore ways to link behavior change for medication adherence with lifestyle modification for diet and physical activity. 3. To conduct cost evaluations for the telephone intervention vs. standard care.
Interventions
- BEHAVIORAL Tailored telephone intervention of education
- BEHAVIORAL Print educational intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 556 participants |
| Start Date | 2003-07 |
| Est. Completion | 2008-07 |
| Phase | NA |
What the finished NCT00179374 record still lists
NCT00179374 is an interventional study that assigns participants to a tested intervention. The registered 556 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which Tailored telephone intervention of education is the first listed.
NCT00179374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00179374 about?
NCT00179374 is a clinical study titled "Improving Diabetes Outcomes With Activity, Nutrition and Medication". This study has the following specific aims: 1. A tailored telephone intervention will significantly improve medication adherence compared to a standard care intervention. 2. A tailored telephone intervention will significantly improve metabolic control measured by HbA1c compared to a standard care ...
What is the current status of trial NCT00179374?
This trial is currently completed. It is a NA study. The enrollment target is 556 participants. The study started on 2003-07. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00179374?
The interventions under investigation include: Tailored telephone intervention of education (BEHAVIORAL), Print educational intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00179374?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00179374's enrollment target sits among peer trials
556 184th of 2000 higher than 1,817 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- NCT06693622 · 556 participants
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT06799000 · 555 participants · Phase 3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia